Single photon emission computed tomography in Alzheimer's disease and related disorders.
Alzheimer's disease and other dementia syndromes can be characterized by single photon emission computed tomography (SPECT). SPECT can be used to measure cerebral blood flow or neurotransmitter activity in these disorders. SPECT can help distinguish various neurologic disorders and also help elucidate their pathophysiologic processes. This article focuses on the use of SPECT in the study of Alzheimer's disease and related neurologic disorders.
Newberg
A B
AB
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, USA.
Alavi
A
A
Payer
F
F
D000368:Aged; D000375:Aging; D000544:Alzheimer Disease / Q000000981:diagnostic imaging*; D001927:Brain Diseases / Q000000981:diagnostic imaging*; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging; D003704:Dementia / Q000000981:diagnostic imaging; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon / Q000295:instrumentation / Q000379:methods
D018377:Neurotransmitter Agents